Indoco Remedies is currently trading at Rs. 123.45, up by 0.55 points or 0.45 % from its previous closing of Rs. 122.90 on the BSE.
The scrip opened at Rs. 122.90 and has touched a high and low of Rs. 123.65 and Rs. 122.80 respectively. So far 5096 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 161.65 on 06-Jan-2014 and a 52 week low of Rs. 55.05 on 31-Jul-2013.
Last one week high and low of the scrip stood at Rs. 126.00 and Rs. 114.60 respectively. The current market cap of the company is Rs. 1137.60 crore.
The promoters holding in the company stood at 59.22% while Institutions and Non-Institutions held 16.65% and 24.13% respectively.
Indoco Remedies has received Certificate of Good Manufacturing Practice (GMP) Compliance from State Institute for Drug Control (SUKL), Czech Republic. The company received GMP Compliance for their Goa Plant II located at Verna Industrial Estate, Goa. The certificate pertains to manufacture of Sterile Ophthalmic Formulations.
The GMP certificate confirms that the plant fulfills the GMP recommendation of World Health Organization (WHO). The plant has been inspected in connection with marketing authorization(s) listing manufacturers located outside of the European Economic Area.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1792.70 |
Dr. Reddys Lab | 1199.15 |
Cipla | 1549.00 |
Lupin | 2135.55 |
Zydus Lifesciences | 875.15 |
View more.. |